Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma.
L M Mittlmeier1, M Unterrainer2, A Todica2
1Department of Urology, University Hospital, LMU Munich, Munich, Germany; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Urology
|March 16, 2020
Summary
Metanephric adenoma, a rare renal tumor, is challenging to diagnose noninvasively. This case highlights advanced molecular imaging, including 18F-PSMA-1007 PET/CT, for better diagnosis.
Area of Science:
- Oncology
- Radiology
- Molecular Imaging
Background:
- Metanephric adenoma (MA) is a rare renal neoplasm, typically benign but with metastatic potential.
- Accurate noninvasive diagnosis of MA remains a clinical challenge using conventional imaging modalities.
Observation:
- This report details a histologically confirmed case of metanephric adenoma.
- The diagnostic workup incorporated advanced molecular imaging techniques.
Findings:
- 18F-PSMA-1007 PET/CT demonstrated high avidity in the primary tumor.
- 99mTc-Sestamibi SPECT and contrast-enhanced ultrasound provided complementary anatomical and functional information.
- Integrated molecular and conventional imaging facilitated a more comprehensive assessment of the MA.
Implications:
- Advanced molecular imaging may improve the diagnostic accuracy of metanephric adenoma.
- This approach could potentially aid in differentiating benign MA from malignant renal tumors.
- Further research into molecular imaging for rare renal tumors is warranted.
More Related Videos
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.6K
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
8.7K